equol has been researched along with Dyslipidemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daimon, M; Hamaura, K; Iino, K; Matsuki, K; Mikami, T; Murakami, H; Oishi, M; Okuyama, S; Sato, E; Tamura, A; Tanabe, J; Uchiyama, S; Ueno, T; Yanagimachi, M; Yokoyama, Y | 1 |
| Beydoun, HA; Jeng, HA; Kantaria, K | 1 |
2 other study(ies) available for equol and Dyslipidemia
| Article | Year |
|---|---|
Association between equol producers and type 2 diabetes mellitus among Japanese older adults.
Topics: Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Dyslipidemias; East Asian People; Equol; Female; Gastrointestinal Microbiome; Glycine max; Humans; Isoflavones; Male; Phytoestrogens; Postmenopause; Sex Factors | 2023 |
Urinary phytoestrogens in relation to metabolic disturbances among children and adolescents.
Topics: Adolescent; Blood Glucose; Blood Pressure; Body Mass Index; Child; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Dyslipidemias; Equol; Genistein; Glucose; Glucose Intolerance; Humans; Lipid Metabolism; Phytoestrogens; Triglycerides | 2015 |